Hello
I know that we have previously requested your comments about olaparib and some of you have very helpfully shared your experiences. We are preparing a submission to NICE regarding olaparib becoming routinely available for second-line treatment on the NHS.
The name of the NICE consultation is: Olaparib for maintenance treatment of recurrent, platinum-sensitive ovarian, fallopian tube and peritoneal cancer that has responded to platinum-based chemotherapy.
It would be really helpful if any of you who are taking or have taken olaparib have comments you'd be willing for us to share within our submission - we wouldn't use your name or any identifying details.
Do get in touch if you have any questions.
Many thanks for your help, as always.
Best wishes
Julia (Ovacome Support Services Officer)